{"schema_version":"secwatch.filing_event.v1","accession":"0000879169-26-000046","form_type":"8-K","ticker":"INCY","cik":"0000879169","company_name":"INCYTE CORP","filed_at":"2026-06-22T11:00:40+00:00","discovered_at":"2026-06-22T11:05:01.252129+00:00","generated_at":"2026-06-22T11:05:33.109837+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Incyte settles CMS dispute over Opzelura Medicaid rebates; records $246M benefit","bullets":["CMS will not apply line extension regulation to Opzelura as if it were a line extension of Jakafi; Incyte withdraws lawsuit.","One-time non-cash benefit of ~$246M in Q2 2026 from reversal of previously accrued liabilities through March 31, 2026.","No future accruals for potential line extension regulations; expects improvement to Opzelura's gross-to-net.","Company plans to update financial guidance on next scheduled earnings release."],"urls":{"canonical":"https://secwatch.observer/filing/0000879169-26-000046","json":"https://secwatch.observer/filing/0000879169-26-000046.json","markdown":"https://secwatch.observer/filing/0000879169-26-000046.md","text":"https://secwatch.observer/filing/0000879169-26-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/0000879169-26-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/879169/000087916926000046/incy-20260622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T11:05:33.109837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}